NEW YORK--(BUSINESS WIRE)--Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals’ (SLXP) Hepatic Encephalopathy Living Program (H.E.L.P.) (www.HELPenroll.com). H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550® (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy (HE) recurrence. It is a first-of-its-kind patient and healthcare provider support program for the management of HE, and will provide patients with educational materials, co-pay assistance, treatment adherence support, and a 24-hour toll-free hotline.
